Health
Aptorum Group Limited Announces Pricing Of $3.0 Million Registered Direct Offering
(MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company ...
By: menafn
- Jan 02 2025
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS